**Core Concept**
Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic disorders characterized by ineffective hematopoiesis, leading to cytopenias and an increased risk of progression to acute myeloid leukemia (AML). Cytogenetic abnormalities play a crucial role in the pathogenesis and prognosis of MDS.

**Why the Correct Answer is Right**
The most common cytogenetic abnormality in adult MDS is a deletion of the long arm of chromosome 5, also known as -5 or del(5q). This deletion is often associated with the refractory anemia with deletion 5q (RASD5q) subtype of MDS. The deletion leads to the loss of the 5q31-q35 region, which contains genes involved in cell cycle regulation and apoptosis. Patients with RASD5q often have a more favorable prognosis compared to those with other cytogenetic abnormalities.

**Why Each Wrong Option is Incorrect**
**Option A:** Monosomy 7 (-7) is a common cytogenetic abnormality in MDS, but it is not the most common. Monosomy 7 is associated with a poorer prognosis and a higher risk of progression to AML.
**Option B:** Trisomy 8 (8+ or +8) is another common cytogenetic abnormality in MDS, but it is not as common as del(5q). Trisomy 8 is often associated with a more aggressive disease course.
**Option C:** Complex karyotypes involving multiple chromosomal abnormalities are more common in secondary AML than in primary MDS. While complex karyotypes can occur in MDS, they are not the most common cytogenetic abnormality.

**Clinical Pearl / High-Yield Fact**
The International Prognostic Scoring System (IPSS) and the revised IPSS (IPSS-R) are widely used to predict the prognosis of patients with MDS. The IPSS-R takes into account both cytogenetic and molecular abnormalities to provide a more accurate risk stratification.

**Correct Answer: D. del(5q)**